![Noble gas therapy for myocardial diseases: Xenon-based therapy for heart regeneration and repair: Inhalation of Xenon gas increases Agrin expression, activates Yap and ERK-mediated signaling, replaces scar tissue with functional cardiomyocytes, and Noble gas therapy for myocardial diseases: Xenon-based therapy for heart regeneration and repair: Inhalation of Xenon gas increases Agrin expression, activates Yap and ERK-mediated signaling, replaces scar tissue with functional cardiomyocytes, and](https://genomediscovery.org/wp-content/uploads/2018/03/Xenon-protects-against-diabetic-cardiomyopathy-and-myocardial-infarction-through-up-regulation-of-Agrin.jpg)
Noble gas therapy for myocardial diseases: Xenon-based therapy for heart regeneration and repair: Inhalation of Xenon gas increases Agrin expression, activates Yap and ERK-mediated signaling, replaces scar tissue with functional cardiomyocytes, and
![Noble gas therapy for cardiomyopathy: Xenon gas inhalation therapy for Cardiomyopathy: Inhalation of xenon gas decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins, and alleviates Cardiomyopathy, Noble gas therapy for cardiomyopathy: Xenon gas inhalation therapy for Cardiomyopathy: Inhalation of xenon gas decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins, and alleviates Cardiomyopathy,](https://genomediscovery.org/wp-content/uploads/2018/03/Xenon-inhaltion-therpay-for-cardiomyopathy.jpg)
Noble gas therapy for cardiomyopathy: Xenon gas inhalation therapy for Cardiomyopathy: Inhalation of xenon gas decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins, and alleviates Cardiomyopathy,
![Mallinckrodt, NPXe Announce FDA Fast Track Designation for Inhaled Xenon Gas Therapy Trial | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Mallinckrodt, NPXe Announce FDA Fast Track Designation for Inhaled Xenon Gas Therapy Trial | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](http://media.americanpharmaceuticalreview.com/m/28/article/353000-333x250.jpg)
Mallinckrodt, NPXe Announce FDA Fast Track Designation for Inhaled Xenon Gas Therapy Trial | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
![Noble gas therapy for blood sugar disease: Xenon gas inhalation therapy for autoimmune diabetes (TIDM): Inhalation of Xenon gas increases PD-L1 expression, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation Noble gas therapy for blood sugar disease: Xenon gas inhalation therapy for autoimmune diabetes (TIDM): Inhalation of Xenon gas increases PD-L1 expression, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation](https://genomediscovery.org/wp-content/uploads/2018/03/Xenon-may-protect-against-autoimmune-diabetes-T1DM-through-up-regulation-of-PD-L1.jpg)
Noble gas therapy for blood sugar disease: Xenon gas inhalation therapy for autoimmune diabetes (TIDM): Inhalation of Xenon gas increases PD-L1 expression, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation
![Added by @xenon.care Instagram post Application Of Xenon Gas in theraputic way helps increases cerebral blood flow which supports human body in case of cerebral injury or stroke. . . . Book Added by @xenon.care Instagram post Application Of Xenon Gas in theraputic way helps increases cerebral blood flow which supports human body in case of cerebral injury or stroke. . . . Book](https://scontent-iad3-1.cdninstagram.com/v/t51.2885-15/fr/e15/s1080x1080/84514535_817472708730930_2632893903626893641_n.jpg?_nc_ht=scontent-iad3-1.cdninstagram.com&_nc_cat=106&_nc_ohc=xJ0rVuwHq6EAX9ZOT4X&oh=1389d1799a4d194821818a99a9b77444&oe=5E93CB41)